| 
Citations
 | 
   web
Klumpp, L., Sezgin, E. C., Skardelly, M., Eckert, F., & Huber, S. M. (2017). KCa3.1 channels and glioblastoma: in vitro studies. Curr Neuropharmacol, .
toggle visibility
Guerrero, P. A., Tchaicha, J. H., Chen, Z., Morales, J. E., McCarty, N., Wang, Q., et al. (2017). Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression. Oncogene, .
toggle visibility
Magrath, J. W., & Kim, Y. (2017). Salinomycin's potential to eliminate glioblastoma stem cells and treat glioblastoma multiforme (Review). Int J Oncol, 51(3), 753–759.
toggle visibility
Miranda, A., Blanco-Prieto, M., Sousa, J., Pais, A., & Vitorino, C. (2017). Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches. Int J Pharm, 531(1), 372–388.
toggle visibility
Yin, J., Oh, Y. T., Kim, J. - Y., Kim, S. S., Choi, E., Kim, T. H., et al. (2017). Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPbeta Signaling. Cancer Res, 77(18), 4973–4984.
toggle visibility